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Incidence, mortality and cancer risk in neurofibromatosis 1: A total population study in 
Finland
S Peltonen,1 E Uusitalo,2 J Leppävirta,1 E Pukkala,3 M Pöyhönen4 and J Peltonen2 1 
Department of Dermatology, University of Turku and Turku University Hospital, Turku, 
Finland, 2 Department of Cell Biology and Anatomy, University of Turku, Turku, Finland, 3 
Finnish Cancer Registry, Helsinki, Finland and 4 Department of Clinical Genetics, HUSLAB, 
Helsinki University Central Hospital, Helsinki, Finland
Neurofibromatosis 1 (NF1) is the most common monogenic cancer syndrome with diagnostic find-
ings in skin. The purpose of this study was to elucidate the incidence, cancer risk and mortality of 
NF1 in a register study covering whole Finland with population of 5.4 million. The patients were 
searched in hospital records using ICD codes, and the diagnoses were confirmed in medical records 
and death certificates. The NF1 cohort contained 1388 patients from 980 different families with 
year of birth between 1905 and 2011. The highest incidence of 1/1871 was noted in three year 
period 1994-1996. This was significantly higher than the generally accepted incidence of 1/3000. 
The NF1 cohort was cross-referenced with Causes of Death Register, and the follow up for cancer 
was carried out through the files of the Finnish Cancer Registry using the personal identification 
number as a key. During the follow up period of 1987-2011, a total of 201 cases of cancer were 
diagnosed while the expected number was 42.51 cases in the reference population (standardized 
incidence ratio (SIR) 4.73. The incidence of malignant peripheral nerve sheath tumors (MPNSTs) 
was highly elevated (SIR 1354.06). The incidence of breast cancer was elevated especially in the 
age group of 30-44 years, with SIR 7.72. The proportionate mortality ratios (PMR) for all cancers in 
patients with NF1 in different age groups were as follows: 0-19 yrs PMR 54.07; age group 0-49 yrs 
PMR 26.65; and age group >50 yrs PMR 2.95. The mean age at death was 52.30 yrs in men and 
51.89 yrs in women, and the life expectancy of NF1 patients was 16,8 years shorter in men and 
26,3 shorter in women when compared to general Finnish population. These results show that NF1 
is a life threatening disease with higher incidence than previously accepted.    
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Risk of stroke following herpes zoster: a self-controlled case-series study 
S Langan, C Minassian, L Smeeth and S Thomas London School of Hygiene and Tropical 
Medicine, London, United Kingdom
Herpes zoster is common and vaccine preventable. Stroke risk may be increased following zoster, 
but evidence is sparse and could be explained by differences between people with and without 
zoster. Our objective was to determine if stroke risk is increased following zoster. Within-person 
comparisons were undertaken using the self-controlled case-series method and data from the UK 
General Practice Research Database (1987-2012). Participants had a first-ever diagnosis of zoster 
and stroke within the study period. Stroke incidence in periods following zoster was compared with 
incidence in other time periods. Age-adjusted incidence ratios and 95% confidence intervals were 
calculated. 6,584 individuals were included. Stroke rate was increased following zoster compared 
to the baseline unexposed period then gradually reduced over six months: weeks 1-4 (age-adjusted 
incidence ratio (IR) 1.63, 95% CI 1.32-2.02), weeks 5-12 (IR 1.42, 95% CI 1.21-1.68), and weeks 
13-26 (IR 1.23, 95% CI 1.07-1.42), with no increase thereafter. A stronger effect was observed for 
individuals with zoster ophthalmicus, rising to greater than three-fold rate 5-12 weeks after zoster. 
Oral antivirals were given to 55% of individuals: incidence ratios for stroke were smaller among 
those receiving antivirals compared to those not treated, suggesting a protective effect. We have 
established an increased stroke rate within six months following zoster. Findings have implications 
for zoster vaccination programmes which may reduce stroke risk following zoster. The low antiviral 
prescribing rate needs to be improved; our data suggest that antiviral therapy may lead to a reduced 
stroke risk following zoster.    
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Suicidal thoughts in patients with common skin diseases across Europe 
F Dalgard,2 U Gieler1 and J Kupfer1 1 Justus-Liebig University, Giessen, Germany and 2 
Innlandet Hospital TRust, Brumundal, Norway
The psycho-social burden of chronic skin diseases has been acknowledged and attention has been 
brought to suicidal ideation among dermatological patients. The objective of this study is to assess 
the prevalence of suicidal thoughts among patients with common skin diseases across Europe. The 
design is cross-sectional; a questionnaire was filled in by 250 consecutive dermatological out-pa-
tients and 125 healthy controls in 13 countries in Europe. The questionnaire included socio-de-
mographic background information; stress was assessed with number of life events during the last 
six months, depressive co-morbidity was assessed with the Hospital Anxiety and Depression Scale, 
and two items on suicidal ideation were included: “suicidal thoughts ever” and “suicidal thoughts 
because of skin disease”. The total number of responders was 4994. Overall the prevalence of sui-
cidal ideation was 12.7% among dermatological patients compared to 8.3% in the control group, 
and 6.7% of the patients reported suicidal ideation because of their skin disease. More females than 
males reported suicidal ideation (13.6% vs 11.3%). The highest rate of suicidal ideation among 
patients was in Turkey (17.5%), Belgium (17.4%), and Hungary (14.5%). The highest rate of sui-
cidal ideation was for patients with leg ulcers (17.8%) and psoriasis (17.3%). The association with 
suicidal ideation was strongly significant for patients with psoriasis with an OR 1.94 (1.33; 2.82) in 
a model adjusting for socio-demographical factors, stress and depression. This study demonstrates 
the burden of common skin diseases by emphasizing the high prevalence of suicidal thoughts among 
dermatological out-patients across Europe.    
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Atopic dermatitis disease control and age: A cohort study 
K Abuabara,1 DJ Margolis,1 O Hoffstad2 and A Troxel2 1 Dermatology, University 
of Pennsylvania, Philadelphia, PA and 2 Biostatistics and Epidemiology, University of 
Pennsylvania, Philadelphia, PA
The aim of this prospective observational cohort study was to describe the longitudinal course of 
atopic dermatitis (AD) disease control and assess whether the odds of a period of apparent remission 
(complete disease control without the use of medications) increases with age. We studied 5,798 
children with AD diagnosed by a physician and enrolled in the Pediatric Eczema Elective Registry. 
Self-reported disease control and medication use were assessed every 6 months for up to 9 years. The 
mean age of AD onset was 2.2 (SD 3.0), of enrollment was 7.2 (SD 3.1), and the mean duration of 
follow-up was 4.2 years (SD 2.6). Overall, good and limited control were reported most frequently 
(80% of responses). The subject-specific odds of apparent remission increased with age (adjusted OR 
1.78 (95% CI 1.72-1.83)); however only 21% of the population ever reported a 6-month period with 
apparent remission. Among those, 45% subsequently reported disease activity or medication use, 
suggesting that a minority of children outgrew their disease. The subject-specific odds of a period 
of apparent remission increased with age, but few patients achieved this outcome. Most patients 
in the PEER cohort continue to have active disease with good or limited control into their teens.   
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Impact of psoriasis severity on uncontrolled hypertension: a population-based study in the 
United Kingdom
J Takeshita,1 S Wang,3 DB Shin,1 NN Mehta,2 SE Kimmel,1 DJ Margolis,1 AB Troxel1 and 
JM Gelfand1 1 University of Pennsylvania, Philadelphia, PA, 2 National Heart Lung and Blood 
Institute, Bethesda, MD and 3 Rutgers Robert Wood Johnson, Piscataway, NJ
Hypertension is an important modifiable cardiovascular disease risk factor that is prevalent among 
psoriasis patients. The aim of our study was to assess the impact of psoriasis and its severity as 
objectively determined by affected body surface area (BSA) on blood pressure control among patients 
with diagnosed hypertension. We performed a population-based, cross-sectional study using the 
Incident Health Outcomes and Psoriasis Events (iHOPE) cohort which consists of a random sample 
of psoriasis patients in The Health Improvement Network (THIN), an electronic medical records 
database in the UK. In addition to being diagnosed with hypertension, included psoriasis patients 
(N=1,322) had their psoriasis extent determined by their general practitioner. Psoriasis patients were 
matched with up to 10 patients with hypertension and without psoriasis (N=11,977). The outcome 
was uncontrolled hypertension (systolic blood pressure >140 mmHg or diastolic blood pressure 
>90 mmHg). We found a significant positive dose-response relationship between uncontrolled 
hypertension and psoriasis severity in both unadjusted and adjusted analyses that controlled for age, 
sex, body mass index, smoking and drinking status, co-morbid disease, and current antihypertensive 
and non-steroidal anti-inflammatory drug use (adjusted odds ratios [OR] 0.97, 95% confidence 
interval [CI], 0.82-1.13 for mild; 1.20, 95% CI, 0.99-1.45 for moderate; and 1.48, 95% CI 1.08-2.04 
for severe psoriasis; p for trend=0.01). The greatest likelihood of uncontrolled hypertension was 
observed among patients with moderate-to-severe psoriasis (≥ 3% BSA). Our findings were robust 
to multiple sensitivity analyses. Our results suggest that patients with concomitant hypertension 
and psoriasis, particularly those with more severe disease, may require stricter blood pressure 
management than hypertensive patients without psoriasis.    
228
Geographic distribution of Cutaneous T-Cell Lymphoma cases in Houston and Texas: a com-
parison of the MD Anderson and Texas Cancer Registries
I Litvinov,4 M Tetzlaff,3 E Rahme,2 K Pehr,4 P Gangar,1 D Sasseville4 and M Duvic1 1 
Dermatology, MD Anderson Cancer Center, Houston, TX, 2 Clinical Epidemiology, McGill 
University, Montreal, QC, Canada, 3 Pathology, MD Anderson Cancer Center, Houston, TX 
and 4 Dermatology, McGill University, Montreal, QC, Canada
Reports of occurrence of Mycosis Fungoides in married couples and families raise the possibility 
that there might be an important environmental trigger for this disease. While it was suggested 
that Cutaneous T-Cell Lymphoma (CTLC) arises from inappropriate T cell stimulation, currently no 
definitive preventable trigger has been identified. In the current work we analyzed by region, zip 
code, age, sex and ethnicity the demographic data of 1047 patients from Texas, who were seen 
in a CTCL clinic at the MD Anderson Cancer Center during 2000-2012 (the MDACC database) 
and 1990 patients that were recorded in the Texas Cancer Registry (TCR database) between 1996-
2010. Subsequently data from both databases was cross analyzed and compared. Our findings, 
based on the MDACC database document geographic clustering of patients in three communities 
within the Houston metropolitan area, where CTCL incidence rates were 5-20 times higher than 
the documented population rate and patients with this rare cancer were residing along the same 
street/highway. Moreover, Fisher’s exact test analysis of incidence rates in these communities over 
time suggests a significant increase after ~2005. Analysis of the TCR database defined the CTCL 
population rate for the state to be 5.77 [95% CI 5.52, 6.03] cases per million individuals per year, 
confirmed the observations from the MDACC database and further highlighted additional putative 
areas of geographic clustering for CTCL across Texas. In conclusion, our study documents geo-
graphic clustering of CTCL cases and argues for the existence of yet unknown external triggers for 
this rare cancer. Identification of additional CTCL clusters around the world will potentially help 
identify these triggers and will bring us closer to preventing this disease.    
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A Cochrane Systematic Review of Interventions for Hidradenitis Suppurativa
JR Ingram,1 N Desai,2 A Kai,2 S Chua,3 P Woo,4 F Kerdel,5 T Burton,6 AD Ormerod,7 K Hood1 
and V Piguet (ESDR)1 1 Cardiff University, Cardiff, United Kingdom, 2 St John’s Institute of 
Dermatology, London, United Kingdom, 3 University Hospitals Birmingham NHS Foundation 
Trust, Birmingham, United Kingdom, 4 Northampton General Hospital, Northampton, 
United Kingdom, 5 Florida Academic Dermatology Centers, Miami, FL, 6 HS Trust, Chatham, 
United Kingdom and 7 University of Aberdeen, Aberdeen, United Kingdom
The aim of this Cochrane review was to summarise the strength and quality of evidence for treat-
ment of hidradenitis suppurativa (HS). Our review included randomised controlled trials (RCTs) 
of all interventions for HS. Within-participant trials were permitted if they compared the left and 
right sides of the same anatomical region. Electronic databases and trial registers were searched up 
to November 2013 and dermatology conference proceedings were hand searched. Two authors 
independently performed data extraction and risk of bias assessment. Ten RCTs were included, with 
a total of 573 participants. Primary outcomes for our review were dermatology-specific quality of 
life, included in four studies, and adverse effects, included in all 10 studies. Topical clindamycin 
was investigated in two trials and results of a head-to-head RCT in 34 participants suggest similar 
efficacy to oral tetracycline. Surgical RCTs were limited to one study which found no difference in 
complication rates with or without insertion of a gentamicin sponge after limited excision of active 
HS lesions. Relatively small, unblinded trials suggest that Nd:YAG laser and intense pulsed light 
may have some benefit, particularly for axillary sites. Meta-analysis of two studies demonstrated 
that adalimumab 40mg weekly significantly reduces Dermatology Life Quality Index score after 12 
to 16 weeks (RR -4.00, 95% CI -6.49 to -1.51) whereas adalimumab 40mg every other week does 
not (RR -1.61, 95% CI -3.86 to 0.64). A small trial of infliximab 5mg/kg given at weeks 0,2 and 6 
found benefit at 8 weeks. Etanercept 50mg twice weekly was ineffective. Large gaps remain in RCT 
evidence to guide HS treatments, particularly regarding surgery and oral systemic therapies such as 
antibiotics, retinoids and immunomodulators.    
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A Retrospective Consecutive Case-Series Study on The Effect of Systemic Treatment, Length 
of Admission Time, and Comorbidities in 106 Bullous Pemphigoid Patients Admitted to a 
Tertiary Centre. 
L Kibsgaard,1 B Bay,2 M Deleuran1 and C Vestergaard1 1 Dermato-Venereology, Aarhus 
University Hospital, Aarhus, Denmark and 2 Gynecology/Obstetrics, Aarhus University 
Hospital, Aarhus, Denmark
Bullous pemphigoid is a common blistering disease caused by antibodies directed against hemi-des-
mosomal proteins BPAG1 and BPAG2. The disease is characterized by intense pruritus and blis-
tering of the skin. The systemic treatment with the highest level of evidence for BP is systemic 
glucocorticoids. However, since the disease often occurs in the elderly patients, and since the 
most common co-morbidities are diabetes and neurological diseases, glucocorticoid-sparing drugs 
are often introduced. We retrospectively identified all BP patients admitted to our tertiary clinic 
over a seven-year period in order to register demography, treatment and co-morbidities. The most 
common steroid sparing drug was azathioprine (87%). Methotrexate was second in line (11%) 
whereas 2% were treated with dapsone, rituximab and/or cyclosporine A. As expected, we found 
a relatively high rate of neurological disorders (37%), diabetes (15%) and malignancies (14%), but 
surprisingly we also found an increased rate of cardiovascular diseases (70%) compared to the 
Danish population in general.    
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Acne in adult females - the biophysical parameters
A Erkiert-Polguj and H Rotsztejn Department of Cosmetology and Aesthetic Dermatology, 
Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland
Acne is typically regarded as an adolescent condition, however it often affects adult women. It may 
have a considerable negative psychological, social and emotional impact on patients. Depending 
on the time of onset, the acne in adults may be divided in: ‘persistent’ and ‘late-onset’. Postado-
lescent acne is generally mild-to-moderate in severity and presents mostly inflammatory lesions, 
prominently on the lower chin, jawline and neck. In this age group acne can be often resistant to 
therapy and/or prone to relapse. The data lack complex information about the skin biophysical 
parameters in this group of patients. The aim of the study is to analyse of TEWL, sebum secretion 
and pH value (with worldwide acknowledged biophysical measuring methods) in different parts 
of women face (forehead, cheek, chin, neck) and to evaluate the pathophysiological conditions 
leading to acne. The research is in progress.    
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Characteristics of early-onset and late-onset psoriasis in a Hungarian population
EA Janka, D Sugár, M Lovászi, K Gáspár, E Bodnár, A Szegedi, D Torocsik and ÉVA Remenyik 
Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, 
Hungary
Psoriasis is a chronic, immune-mediated inflammatory skin disease. Based on the appearance of 
the first clinical symptoms it can be divided to early-onset (age of onset<40years) and late-onset 
(age of onset≥40 years) psoriasis. These two subgroups have different characteristics. Our aim was 
to investigate factors specific for early-, and late-onset psoriasis and the presence of accompanying 
co-morbidities. In this study, clinical and laboratory data were collected from 498 adult psoriatic 
patients in a Hungarian university hospital. The patients were divided into early-onset (N=314) and 
late-onset (N=184) groups. The relationship between the severity of psoriasis and the difference of 
data in early-, and late-onset psoriasis was analyzed by multinomial logistic regression. The signif-
icance level was p<0,05. The frequency of co-morbidities in mild, moderate and severe psoriasis 
was demonstrated by 95% confidence intervals (CI). The statistical analysis showed that early-onset 
psoriasis is associated with the existence of hypertension (p=0,049), hyperlipidaemia (p=0,05), 
normal weight (p=0,03) or severe psoriasis (p<0,001 vs. mild; p=0,006 vs. moderate) compared to 
late-onset psoriasis. Among early-onset psoriasis patients the connection was examined between 
severity of psoriasis and factors. There was more significant chance to suffer from moderate than 
mild psoriasis in the case of current smokers (p=0,03). Furthermore, there was also a significantly 
higher chance of having severe psoriasis if someone had a positive family history (p=0,002) or is 
a current smoker (p=0,02). Among late-onset psoriasis patient the analysis showed association 
between severe psoriasis and current smoking (p=0,047) also. In early-onset psoriasis co-morbidities 
were significantly higher among patients with moderate or severe psoriasis than mild psoriasis. 
These results indicate that smoking is a determinative effect on the severity of psoriasis. It is also 
important to pay attention to co-morbidities.    
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Comorbidities in Patients with Psoriasis: New Results- Study on 400 Czech Patiens
K Juzlova,1 M Dzambova,1 J Votrubova,1 Z Smerhovsky,2 J Fialova,1 D Gopfertova2 and 
J Hercogova1 1 Dermatovenereology, Charles University in Prague, Prague, Czech Republic 
and 2 Epidemiology, Charles University In Prague, Prague, Czech Republic
According to recent findings, psoriasis is associated with multiple other diseases called comor-
bidities, which aggravate the quality of life of psoriatic patients, and affect their morbidity and 
mortality. Many studies have already demonstrated that the prevalence of metabolic syndrome, 
atherosclerosis and gastrointestinal diseases is significantly higher in psoriatic patients than in the 
common population. The results of individual studies are highly variable and the conclusions are 
ambiguous. No similar study has been performed yet in Czech psoriatic patients. We therefore ini-
tiated a project aimed at identifying the presence of risk factors and early stages of selected diseases 
that represent important comorbidities. The study was designed as a hospital- based case-control 
study. The cases and controls were selected from outpatients and inpatients of Dermatovenereology 
ward of the Bulovka Hospital. 131 cases and 267 controls were included in the study. Psoriasis 
cases have a higher blood pressure than controls, a bigger waist circumference and larger BMI 
value. The cases have a higher leucocyte count and titres gliadine IgA antibodies as well. In cases, 
the HDL level is significantly lower. Another difference between cases and controls was in glucose 
concentration. Using binary logistic regression psoriasis has been positively associated with diastolic 
blood pressure, BMI value and leucocytosis. The association between glucose concentration and 
psoriasis is negative. The comparison revealed statistically significant differences in terms of several 
observed parameters. The dispensary care for psoriatic patients should focus especially on secondary 
prevention of predisposing diseases.    
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Epidemiological research on basal cell carcinoma in Morocco
H Hami,1 A Ayoujil,2 F Habib,6 A Soulaymani,3 A Mokhtari4 and A Quyou5 1 Laboratory 
of Genetics and Biometry, Faculty of Science, Ibn Tofail University, Kenitra, Morocco, 2 
Laboratory of Genetics and Biometry, Faculty of Science, Ibn Tofail University, Kenitra, 
Morocco, 3 Laboratory of Genetics and Biometry, Faculty of Science, Ibn Tofail University, 
Kenitra, Morocco, 4 Laboratory of Genetics and Biometry, Faculty of Science, Ibn Tofail 
University, Kenitra, Morocco, 5 Laboratory of Genetics and Biometry, Faculty of Science, 
Ibn Tofail University, Kenitra, Morocco and 6 Al Azhar Oncology Center, Rabat, Morocco
Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer worldwide. The aim 
of this study is to determine the frequency and the epidemiological characteristics of basal cell 
carcinoma in Morocco. This is a descriptive retrospective study of all patients treated for basal cell 
carcinoma at Al Azhar Oncology Center in Rabat between 1994 and 2004. During this 11-year 
period, there were 41 new cases diagnosed with BCC at Al Azhar Oncology Center, accounting 
for 37.6% of all skin cancers and 0.6% of all cancers reported during the study period. More than 
two-thirds of the patients (70.7%) were men with a male-female ratio of 2.4. The average age at 
diagnosis of BCC was 65.5±14.4 years (range 35-93 years). The risk of developing the disease is 
associated with age, 73.2% of cases were diagnosed in patients aged 60 years and older at the time 
of diagnosis and 68.4% in those aged 60-84 years. Two women were diagnosed with metastatic 
disease. Among the cases for whom the outcome was known, a 46-year-old woman died from 
the disease within one year of diagnosis. The most recent estimates of non-melanoma skin cancer 
incidence and mortality in the world reveal sharp differences between developed and developing 
countries possibly related to missed opportunities for early diagnosis and incomplete reporting of 
non-melanoma skin cancer in Africa.    
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High prevalence of skin diseases and need for treatment in a middle-aged population. A 
Northern Finland Birth Cohort 1966 study
S Sinikumpu,1 L Huilaja,1 J Jokelainen,2 J Auvinen,2 M Timonen2 and K Tasanen1 1 
Department of Dermatology, University of Oulu, Oulu, Finland and 2 Institute of Health 
Science, University of Oulu, Oulu, Finland
To determine the overall prevalence of skin diseases and the association of skin disorders and sex 
or socioeconomic status a whole-body skin examination was performed for 1,932 members (46-
years of age) of the Northern Finland Birth Cohort (NFBC 1966). NFBC 1966 is a comprehensive 
longitudinal research program (N=12,058). The cohort members have been evaluated regularly since 
birth by means of health questionaires and clinical examinations. For the purpose of this study visual 
observation of the skin was performed by a specialist of dermatology or an experienced resident, all 
cutaneous findings were documented in a computerized database and the cohort members were 
classified into subgroups according to their need for treatment. A high prevalence of all skin diseases 
needing treatment was found (60 %, N=1,158). Half of the cases of skin findings were evaluated 
to be serious enough to require diagnostic evaluation, treatment or follow-up either in a general 
health care, occupational health care or a secondary care setting. The remaining half were thought 
to be slight and self-treatment was advised. Males (70%) had more skin diseases needing treatment 
than females (52%) (P<0.001). The most common skin finding was a benign skin tumor, which was 
found in every cohort member. Skin infections (44%), eczemas (27%) and sebaceous gland diseases 
(27%) were the most common skin diseases in the cohort. Moreover, skin infections and eczemas 
were more commonly seen in the group with low education compared to those with high education 
(P<0.005). When compared to females, most eczemas and mycotic and bacterial infections were 
more common in male cohort members, whereas hand eczema and rosacea affected more females. 
The results strengthen the postulate that skin diseases are common in an adult population. The high 
overall prevalence of skin diseases and the great need of treatment warrant further epidemiologic 
studies on the factors which are associated with skin diseases.    
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Incidence of malignancies in heart transplant recipients. The retrospective cohort study in 
Czech republic. 
Z Secˇníková,2 M Dzambová,2 D Gopfertová,1 Z Šmerhovský,1 L Hošková3 and J Hercogová2 
1 Epidemiology Dept., 2nd Medical Faculty Charles University in Prague, Prague, Czech 
Republic, 2 Dermatovenereology Dept., 2nd Medical Faculty Charles University in Prague 
and Bulovka Hospital, Prague, Czech Republic and 3 Cardiology Dept., Institute of Clinical 
and Experimental Medicine, Prague, Czech Republic
Malignancy is an important complication among heart transplant recipients. The incidence, spec-
trum and clinical impact of post-transplant tumours were investigated in a single centre study. Data 
of 603 patients who underwent HT between 1993-2010 in the Institute of Clinical and Experimental 
Medicine in Prague, Czech Republic were retrospectively evaluated for skin cancer, solid organ 
tumours and post-transplant lymphoproliferative disease. Only tumours with histopathological 
verification were included. The relation between exposure and the incidence of malignancies was 
described by standardized morbidity ratio (SMR). We investigated 603 patients (495 men and 110 
women) while 191 de novo malignancies had developed in 123 HTR (20.4%).Skin cancer was 
the most frequent type of malignancy (n=119). The median time to develop nonmelanoma skin 
malignancy (NMSC) was 10 years. SCC represented the most frequent type of NMSC (n=62, 52.1 %) 
followed by BCC (n= 37, 31.1 %). Adjusted relative risk (SIR) for developing skin cancer was 94.96 
%.Lung cancer (n=22) was the second most frequent type after NMSC. Median time to develop lung 
cancer was 6 years in men and 3 years in women, average survival time was 1.6 years ( ± 1,08). 
Urogenital tumours (n=10) were detected among 10 HT recipients and median time to diagnosis was 
5.5 years. 13 patients in our cohort developed PTLD (12 men, 1 woman). Mean time to reach the 
diagnosis was 8 years. Cancer is a meaningful complication for long-term survival in HTR whereas 
post-transplant malignancies have variable clinical impact. Outcomes of this study are consistent 
with previous studies, with NMSC and lung cancer as the most frequent malignancies in HTR.   
238
Incidence of skin cancer in the Czech renal transplant population
M Dzambova,1 K Juzlova,1 Z Secˇníková,1 D Gopfertova,2 Z Smerhovsky,2 O Viklicky3 and 
J Hercogova1 1 Dermatovenerology Dept., 2nd Medical Faculty, Charles University in Prague, 
Bulovka Hospital, Prague, Czech Republic, Prague, Czech Republic, 2 Epidemiology Dept., 
2nd Medical Faculty, Charles University in Prague, Czech Republic, Prague, Czech Republic 
and 3 Nephrology Dept., Institute of Clinical and Experimental Medicine, Prague, Czech 
Republic, Prague, Czech Republic
The aim of the study id to determine the incidence of skin cancer in renal transplant recipients in 
a single center study and identify risk factors involved in the development of skin malignancy in 
transplant patients in Czech population. A prospective study was performed on a cohort of 240 
patients (172 men and 68 women) after kidney transplantation who were referred for dermatolog-
ical examination in the time period from January 2013 to March 2014. Patients having the skin 
cancer diagnosed before transplant or tumours without histological verification were excluded. In 
the study cohort we detected a total of 56 skin cancers in 17 out of 240 patients (7 %). Basal cell 
carcinoma represented the most common type of skin neoplasm (n = 33, 58,9 %), followed by 
squamous cell carcinoma (n = 17, 30,3 %). Morbus Bowen occurred in 4 patients and 2 patients had 
a malignant melanoma. Adjusted relative risk of nonmelanoma skin cancer will be evaluated using 
the calculation of standardized morbidity ratio (SMR). The presented results are to be considered 
as preliminary as the study has started recently. Nevertheless, the results prove that the frequency 
of NMSC in the study cohort appears to be higher than in general population. The current results 
emphasize the need to improve secondary prevention in the Czech Republic.    
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Itch prevalence, QOL and depression – Results from  GEHIS (German Epidemiological Hemo-
dialysis Itch Study) 
M Weiss,3 T Mettang,1 U Tschulena2 and E Weisshaar3 1 Clinic for Nephrology, German 
Clinic for Diagnostics, Wiesbaden, Germany, 2 Fresenius Medical Care Deutschland GmbH, 
Bad Homburg, Germany and 3 Environmental and Occupational Dermatology, University 
Hospital Heidelberg, Heidelberg, Germany
Chronic Itch (CI; >6 weeks) is a frequent, often underestimated symptom in hemodialysis (HD) 
patients. Epidemiological data concerning HD-associated CI do not exist yet. In order to investigate 
the prevalence of CI and associated factors in HD patients a representative cross-sectional study was 
conducted. A cluster-sample of 25 dialysis units was randomly selected considering the geographical 
distribution in Germany. Prevalence of CI, sociodemographic and clinical data were investigated in 
all participants as well as anxiety and depression (Hospital Anxiety and Depression Scale (HADS) 
and the generic HRQOL (SF 12). Characteristics of CI and disease-specific health-related Quality 
of Life (HRQOL) (ItchyQoL) were assessed in HD patients with CI. CI-severity was assessed using 
a visual analogue scale (VAS). 860 patients were included, 42.8% were female. Mean age was 
67.2 years (SD: 13.4). Point prevalence of CI was 25.2% with a 95% confidence interval (95%-CI) 
of 22.4-28.1%, 12-month prevalence was 27.2% (95% CI 24.1-30.3%). Lifetime prevalence was 
35.2% (95%-CI 31.9-38.3%). Patients aged <70 years suffered significantly more frequently of CI 
than older patients. 60.4% of the patients had already been suffering from CI up to 10 years. HADS 
mean value was 8.5 for anxiety, 9.6 for depression. There was no significant correlation between 
the point prevalence of CI and HADS. Worst CI-severity was 6.5, CI in mean 4.1. Mean CI-severity 
correlated significantly with the ItchyQol (r=0.50). CI patients showed significantly worse values 
both for the SF-12 physical and mental component summaries. The 1st epidemiological study on the 
prevalence of CI in HD patients shows a high impairment in HRQOL due to CI. Furthermore data 
of all HD patients show borderline results regarding mental status. CI needs to be taken seriously in 
HD patients not only because of its frequency but also due to its resulting burden.    
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Modification of incidence of skin diseases due to the financial crisis in Greece
E Klimi Dermatology, TRhriassio, Athens, Greece
.Financial crisis has considerably changed the way of life and the habits of Greek people.We report 
three main diseases whose incidence haw been modifief the last years. A Herpeas zoster The main 
factor that influences its epidemiology is ultra violet irradiation.The number of women affected 
with this disorder was reduced comparing to men the years 2010-2012 compared 2008-2010.thiw 
may be due to diminished sun exposure due to modificationw of habits and more time spent at 
domestic environment by women, also by reduction of time spent on vacations. B Atopic eczema 
The number of people sufferin from this disorder haw considerably augmented and we have got 
cases os severe atopic eczema even in summer months which is very unusual Reduction to sun 
exposure due to diminished vacation time may account for thiw phenomenon. C Alopecia areata 
is an immune disorderassociated to stress The number of people affected is elevated compared to 
years before rhe financial crisis and most cases occured at the culmination point of the crisis and 
tends to lower again now that seems to come to its end.    
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Responsiveness of the Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) to 
therapies in epidermolysis bullosa and epidermolysis bullosa acquisita
SV Jain,2 CC Loh,2 AG Harris,2 J Kim,2 JC Su,3 BS Daniel,1 SS Venugopal,4 LR Intong,2 
MG Law5 and DF Murrell2 1 Medicine, St Vincent’s Hospital, Sydney, NSW, Australia, 2 
Dermatology, St George Hospital, Sydney, NSW, Australia, 3 Epidermolysis Bullosa Clinic, 
Royal Children’s Hospital, Melbourne, VIC, Australia, 4 Dermatology, Westmead Hospital, 
Sydney, NSW, Australia and 5 Kirby Institute, University of New South Wales, Sydney, NSW, 
Australia
Standardised assessments of disease severity are important to guide patient management and follow 
therapeutic response in clinical trials. Recently, the Epidermolysis Bullosa Disease Activity and 
Scarring Index (EBDASI) was introduced as a valid and reliable tool to measure disease activity 
and damage in epidermolysis bullosa (EB). We aim to further validate the EBDASI by assessing its 
responsiveness to change. A pilot prospective longitudinal study was conducted in 6 patients with 
EB (3 with recessive dystrophic EB, 3 with junctional EB) and 1 patient with epidermolysis bullosa 
acquisita (EBA). The EBDASI was scored by an expert physician on at least two patient visits. 2 
patients showed response to therapy. The patient with EBA receiving monthly rituximab infusions at a 
dosage of 375 mg/m2 of BSA for four consecutive months exhibited partial response, with an EBDASI 
activity score of 54 at baseline and 15 after the fourth infusion. Relapse 12 months post-infusion was 
observed, with an EBDASI activity score of 58. A patient with junctional EB treated with 150mg/
day of thalidomide experienced a reduction in EBDASI activity score from 46 at baseline to 25 at 
month 3, which correlated with a reduction in pain from 8 to 5 on a 10cm visual analogue scale 
and qualitative reports of improved wound healing. 5 EB patients with supportive management had 
stable EBDASI activity scores at follow-up of 3 to 12 months. EBDASI damage scores were stable 
or worsened in all patients. These findings confirm the usefulness of the EBDASI activity score as 
responsive to change in patients’ disease with treatment and time. The EBDASI may be useful in 
quantifying disease severity in clinical practice and in upcoming trials to assess novel therapies in EB.   
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Risk factors for survival in patients with bullous pemphigoid
A Baican,4 V Feldrihan,3 RM Chiorean,1 C Baican,4 DC Leucuta2 and C Sitaru1 1 Department 
of Dermatology, University Medical Center Freiburg, Freiburg, Germany, 2 Department 
of Medical Informatics and Biostatistics, ‘’Iuliu Hatieganu’’ University of Medicine and 
Pharmacy, Cluj-Napoca, Romania, 3 Department of Immunology, ‘’Iuliu Hatieganu’’ 
University of Medicine and Pharmacy, Cluj-Napoca, Romania and 4 Department of 
Dermatology, ‘’Iuliu Hatieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, 
Romania
Bullous pemphigoid is an autoimmune blistering disease, characterized by subepidermal cleavage 
and presence of autoantibodies targeted against hemidesmosomal proteins. The objective of the 
present study was to evaluate the prognosis factors for lethal outcome among patients with bullous 
pemphigoid. We carried out a retrospective, hospital-based cohort study, between April 2001 
and February 2013. The investigated prognostic endpoint was the overall survival of the patients. 
Statistical analysis was performed using the R software environment for statistical computing and 
graphics. A total of 109 patients with bullous pemphigoid have been identified. The median age 
at diagnosis was 73 years (range 17-87). In univariate analysis, the variables identified to increase 
the risk of death, among patients with bullous pemphigoid were: age of onset>83 years (HR=2.73 
(1.32 - 5.67), p-value=0.006 ), presence of an erythrocyte sedimentation rate>30 mm/h (HR=2.66 
(1.3 - 5.43), p-value=0.007) and presence of a history of stroke before diagnosis (HR=3.43 (1.55 - 
7.61), p-value=0.002). Multivariate analysis identified age of onset>83 years (HR=1.08 (1.02 - 1.13), 
p-value=0.004) and presence of an erythrocyte sedimentation rate>30 mm/h (HR=1.02 (1 - 1.04), 
p-value=0.02) as independent risk factors associated with lethal outcome. Older bullous pemphigoid 
patients, with a history of stroke and an erythrocyte sedimentation rate>30 mm/h have a greater 
risk of death. These risk factors should be taken in consideration in the therapeutical approach of 
patients with bullous pemphigoid.    
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Rosacea is associated with upper and lower gastrointestinal symptoms and disorders: results 
of a case-control study 
BM Rainer, A Fischer, D Luz Felipe da Silva, AL Chien and S Kang Dermatology, Johns 
Hopkins School of Medicine, Baltimore, MD
We previously reported that rosacea can be associated with multiple co-morbidities. Isolated reports 
in literature show that gastrointestinal (GI) disorders specifically have been associated with rosacea, 
but no systematic studies have been done to explore this particular association. In this study, our 
objective was to evaluate GI disorders and symptoms as they relate to rosacea. Eligible cases were 
18 years of age and older with a diagnosis of rosacea. Rosacea-free control subjects were age-, sex-, 
and race-matched to each case. Rosacea characteristics were assessed using the National Rosacea 
Society’s standard grading system. A study dermatologist completed clinical evaluations. A struc-
tured interviewer-administered questionnaire collected detailed information on GI disorders and 
associated symptoms, and information on demographics and lifestyle factors. Relative risk estimates 
were calculated using conditional logistic regression as odds ratios (ORs) with 95% confidence 
intervals (CIs). A total of 130 participants were recruited for the study (65 cases/65 controls). The 
mean (standard deviation; SD) age of cases was 50.6 (14.1) years, 43 (66.2%) were females, and 
62 (95.5%) were Caucasians. Mean (SD) duration of disease was 11.8 (9.6) years. Patients had 
significantly higher odds of having GI symptoms overall (estimated OR 22.5; 95% CI, 5.5-92.7; 
p<0.0001), in particular, heartburn (17.5; 4.2-72.8; p<0.0001), flatulence (10.5; 2.5-44.8; p=0.001), 
and constipation (5.0; 1.4-17.3; p=0.01). Significant associations were found between rosacea and 
gastrointestinal reflux disease (GERD) (4.2; 1.7-12.4; p=0.002), and gastritis (4.0; 1.1-14.2; p=0.03). 
Our data demonstrate that rosacea patients were more likely to have symptoms and disorders of 
the upper and lower GI tract. Although rosacea and gastrointestinal disorders represent separate 
entities, they appear to follow overlapping pathogenic pathways.    
   
      
